Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2

by Abdullah-Al-Mamun, M., Ahammad, F., Alam, R., Bouback, T.A, Hossen, M.S, Imon, R.R, Karpiński, T.M, Nain, Z., Nur, S.M, Pokhrel, S., Qadri, I., Rahman, M.S, Samad, A., Talukder, M.E.K, Tareq, M.M.I
Published 2021

Genome-scale CRISPR screens identify host factors that promote human coronavirus infection

by Bluhm, A.P, Grodzki, M., Karst, S.M, Norris, M.H, Rafiee, R., Russo, M., Schaefer, M., Sobh, A., Tagmount, A., Vulpe, C.D
Published 2022

Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19

by Charland, N.C, Filbin, M.R, Goldberg, M.B, Gonye, A.L.K, Gushterova, I., Hacohen, N., Kays, K.R, Khanna, H.K, LaSalle, T.J, Lavin-Parsons, K.M, Leisman, D.E, Lilley, B.M, Lodenstein, C.L, Manakongtreecheep, K., Margolin, J.D, McKaig, B.N, Mehta, A., Parry, B.A, Rojas-Lopez, M., Russo, B.C, Sade-Feldman, M., Sharma, N., Tantivit, J., Thomas, M.F, Thompson, B.T, Villani, A.-C
Published 2022

Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives

by Karakaş, N., Karaoğlan, B.S, Öztürk, G., Shah, K., Üçüncüoğlu, S., Uludağ, D.
Published 2022

Comparative genomic analysis reveals varying levels of mammalian adaptation to coronavirus infections

by King, S.B, Singh, M.
Published 2021

Recurrence, Reactivation, or Inflammatory Rebound of SARS-CoV-2 Infection With Acute Vestibular Symptoms: A Case Report and Revision of Literature

by Camisa, V., Carsetti, R., Garbarino, S., Gilardi, F., Lanteri, P., Magnavita, N., Raponi, M., Santoro, A., Scorpecci, A., Vinci, M.R, Zaffina, S.
Published 2021

Is gut involvement a cause or effect of covid-19?

by Chuah, Y.Y, Lee, Y.Y, Ma, Z.F, Mustaffa, N., Muthukaruppan, R., Tan, P.O, Zulkifli, K.K
Published 2021

A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2)

by Liu, J.-Y, Wang, H.-X, Xu, P.-P, Yu, W.-D, Zeng, M.-S
Published 2021

Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy

by Durvasula, R., Dye, J.M, Fareed, J., Gupta, Y., Herbert, A.S, Kempaiah, P., Kulkarni, C.V, Maciorowski, D., Zak, S.E
Published 2021

Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2

by Ahmad, M., Bhattacharyya, S., Biswal, B.K, Chakraborty, S., Dwivedy, A., Jeyakanthan, J., Kar, D., Majumdar, T., Mani, S., Mariadasse, R., Sonar, S., Tailor, P., Tiwari, S.
Published 2021

Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants

by Gowthaman, R., Guest, J.D, Mittra, I., Pierce, B.G, Quackenbush, J., Taherzadeh, G., Yin, R.
Published 2021